Pharmacologic treatment of postpartum women with new-onset major depressive disorder: A randomized controlled trial with paroxetine

Journal of Clinical Psychiatry

Volumn 69, Issue 4, 2008, Pages 659-665

  Yonkers, Kimberly A ^a   Lin, Haiqun ^a   Howell, Heather B ^a   Heath, A Christopher ^b   Cohen, Lee S ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MULTICENTER STUDY; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; PUERPERAL DEPRESSION; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; SYMPTOMATOLOGY; TREATMENT RESPONSE;

EID: 44849134311     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n0420     Document Type: Article

References (24)

1. Gavin N, Gaynes B, Lohr K, et al. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol 2005;106:1071-1083
2. Yonkers KA, Ramin SM, Rush AJ, et al. Onset and persistence of postpartum depression in an inner-city maternal health system. Am J Psychiatry 2001;158:1856-1863
3. O'Hara MW, Swain AM. Rates and risk of postpartum depression - a meta-analysis. Int Rev Psychiatry 1996;8:37-54
4. Appleby L, Warner R, Whitton A, et al. A controlled study of fluoxetine and cognitive-behavioural counseling in the treatment of postnatal depression. BMJ 1997;314:932-936
5. Gregoire AJP, Kumar R, Everitt B, et al. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996;347:930-933
6. Wisner KL, Perel JM, Peindl KS, et al. Prevention of recurrent postpartum depression: a randomized clinical trial. J Clin Psychiatry 2001;62:82-86
7. Wisner KL, Perel J, Peindl K, et al. Prevention of postpartum depression: a pilot randomized clinical trial. Am J Psychiatry 2004;161:1290-1292
8. Cooper PJ, Murray L. Course and recurrence of postnatal depression: evidence for the specificity of the diagnostic concept. Br J Psychiatry 1995;166:191-195
9. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
10. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/ P, Version 2.0). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1994
11. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education and Welfare publication No. (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976;218-222
12. Rush AJ, Carmody T, Reimitz, PE. The Inventory of Depressive Symptomatology (IDS): Clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. Int J Methods Psychiatr Res 2000;9:45-59
13. Weissman MM, Paykel ES, Prusoff BA. Social Adjustment Scale Handbook: Rationale, Reliability, Validity, Scoring and Training Guide. New York, NY: College of Physicians and Surgeons of Columbia University; 1994
14. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey. Med Care 1992;30:473-481
15. Schraufnagel TJ, Wagner AW, Miranda J, et al. Treating minority patients with depression and anxiety: what does the evidence tell us? Gen Hosp Psychiatry 2006 Jan-Feb;28(1):27-36
16. Brown C, Schulberg HC, Sacco D, et al. Effectiveness of treatments for major depression in primary medical care practice: a post hoc analysis of outcomes for African American and white patients. J Affect Disord 1999;53:185-192
17. Wagner GJ, Maguen S, Rabkin JG. Ethnic differences in response to fluoxetine in a controlled trial with depressed HIV-positive patients. Psychiatr Serv 1998;49:239-240
18. Roy-Byrne PP, Perera P, Pitts CD, et al. Paroxetine response and tolerability among ethnic minority patients with mood or anxiety disorders: a pooled analysis. J Clin Psychiatry 2005;66:1228-1233
19. Green BL, Krupnick JL, Chung J, et al. Impact of PTSD comorbidity on one-year outcomes in a depression trial. J Clin Psychol 2006;62:815-835
20. Peindl KS, Wisner KL. Successful recruitment strategies for women in postpartum mental health trials. J Psychiatr Res 2003;37:117-125
21. Misri S, Reebye P, Corral M, et al. The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial. J Clin Psychiatry 2004 Sept;65(9):1236-1241
22. Wisner K, Hanusa B, Perel J, et al. Postpartum depression: a randomized trial of sertraline versus nortriptyline. J Clin Psychopharmacol 2006;26:353-360
23. Casacalenda N, Perry JC, Looper K. Remission in major depressive disorder: a comparison of pharmacotherapy, psychotherapy, and control conditions [see comment]. Am J Psychiatry 2002;159:1354-1360
24. Posternak MA, Zimmerman M. Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: meta-analysis. Br J Psychiatry 2007;190:287-292